These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies. Tallet B, Astier-Gin T, Moynet D, Londos-Gagliardi D, Guillemain B. AIDS Res Hum Retroviruses; 2001 Mar 01; 17(4):337-48. PubMed ID: 11242520 [Abstract] [Full Text] [Related]
4. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis. Dekaban GA, King EE, Arp J, Palker TJ, Rice GP. Scand J Immunol; 1994 Aug 01; 40(2):171-80. PubMed ID: 8047838 [Abstract] [Full Text] [Related]
6. Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and melanesian strains of human T cell leukemia/lymphoma virus type I. Hoshino H, Nakamura T, Tanaka Y, Miyoshi I, Yanagihara R. J Infect Dis; 1993 Dec 01; 168(6):1368-73. PubMed ID: 7504032 [Abstract] [Full Text] [Related]
8. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1. Jacobson S, Reuben JS, Streilein RD, Palker TJ. J Immunol; 1991 Feb 15; 146(4):1155-62. PubMed ID: 1704032 [Abstract] [Full Text] [Related]
10. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I. Bélec L, Georges-Courbot MC, Georges A, Mohamed AS, Londos-Gagliardi D, Hallouin MC, Hocini H, Guillemain B. J Med Virol; 1996 Sep 15; 50(1):42-9. PubMed ID: 8890040 [Abstract] [Full Text] [Related]
12. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia. Sherman MP, Dube S, Spicer TP, Kane TD, Love JL, Saksena NK, Iannone R, Gibbs CJ, Yanagihara R, Dube DK. Cancer Res; 1993 Dec 15; 53(24):6067-73. PubMed ID: 8261424 [Abstract] [Full Text] [Related]
13. Recognition by human sera of a variable region of the surface glycoprotein of HTLV-I. Edouard E, Londos-Gagliardi D, Busetta B, Geoffre S, Dalbon P, Moreau JP, Guillemain B. Leukemia; 1994 Apr 15; 8 Suppl 1():S65-7. PubMed ID: 8152306 [Abstract] [Full Text] [Related]
14. Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region. Londos-Gagliardi D, Dalibart R, Geoffre S, Dalbon P, Pouliquen JF, Georges-Courbot MC, Sainte-Foie S, Hajjar C, Georges AJ, Moreau JP, Guillemain B. AIDS Res Hum Retroviruses; 1996 Jul 01; 12(10):941-50. PubMed ID: 8798979 [Abstract] [Full Text] [Related]
18. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns. Abrams A, Akahata Y, Jacobson S. Viruses; 2011 Aug 01; 3(8):1320-31. PubMed ID: 21994781 [Abstract] [Full Text] [Related]